Response Biomedical
Vancouver
About Response Biomedical
Response Biomedical Corp. ("Response") (TSX: RBM, OTCBB: RPBIF) develops, manufactures and markets rapid on-site diagnostic tests at its world class manufacturing facility in Vancouver, Canada, for use on the RAMP® Platform. The RAMP® Platform is sold worldwide and includes a variety of testing applications in the clinical, infectious disease, biodefense and environmental arenas. The RAMP® Platform provides laboratory quality results with the speed, precision and accuracy that many hospitals expect of their central lab systems. It is ideally suited for both point of care testing and laboratory use.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $21.7M
- Funding stage: M&A
- Last round: Post-IPO Debt (Feb 2014)
- Ticker: otcbb:RPBIF
- Website: responsebio.com
- Phone: 604-456-6010
Industries & Categories
Biotechnology, Health Diagnostics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/response-biomedical-3199605 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.